4D Molecular stock jumps after positive interim data for eye disease drug (NASDAQ:FDMT)
4D Molecular Therapeutics (NASDAQ:FDMT) shares surged over 60% premarket after the company reported positive interim data for its eye disease drug, 4D-150. Data consists of 24-week results from a randomized…